XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Assets    
Cash $ 291,139 $ 21,432
Prepaid expenses 106,900
Marketable securities held in Trust Account 169,210,110
Deferred offering costs 331,705
Total Assets 169,608,149 353,137
Liabilities and Shareholders’ (Deficit) Equity    
Accrued offering costs and expenses 493,456 30,252
Due to related parties 122
Promissory note - related party 300,000
Deferred underwriting discount 5,862,500
Total current liabilities 6,355,956 330,374
Warrant liabilities 6,320,263
Total Liabilities 12,676,219 330,374
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 16,750,000 and 0 shares at redemption value at December 31, 2021 and 2020, respectively 169,210,110
Shareholders’ (Deficit) Equity:    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 697,500 and 0 shares issued and outstanding (excluding 16,750,000 and 0 shares subject to possible redemption) at December 31, 2021 and 2020, respectively. 70
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 4,287,500 and 5,750,000 shares issued and outstanding at December 31, 2021 and 2020, respectively 429 575
Additional paid-in capital 24,425
Accumulated deficit (12,278,679) (2,237)
Total shareholders’ (deficit) equity (12,278,180) 22,763
Total Liabilities and Shareholders’ (Deficit) Equity $ 169,608,149 $ 353,137